BWCS
BSX icon

Beirne Wealth Consulting Services’s Boston Scientific BSX Stock Holding History

Beirne Wealth Consulting Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,541
Closed -$248K – 126
2025
Q3 		$248K Buy
+2,541
New +$263K 0.06% 186

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Beirne Wealth Consulting Services's BSX Position: Q4 2025 in Review

Beirne Wealth Consulting Services sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,541 shares — an estimated $248K sold.

Beirne Wealth Consulting Services first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $248K in Q3 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Beirne Wealth Consulting Services reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 2,541 Boston Scientific shares in Q4 2025, an estimated $248K.
  • Beirne Wealth Consulting Services first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
  • Beirne Wealth Consulting Services's Boston Scientific position peaked at $248K in Q3 2025.
  • 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Beirne Wealth Consulting Services's 13F filing for Q4 2025, filed 29 Jan 2026.